PCF Science

Apply to join our PCF Science Team! 👇

Today, we partnered with @NBAalumni for a health fair and screening event as part of our #CheckTheBox campaign where we are raising awareness about the power of early detection with a simple PSA blood test. Learn more about prostate cancer screening: bit.ly/4cvZTrL

PCF is proud to award $6.3 million to the next generation of #prostatecancer researchers whose innovative work could drive breakthroughs in prostate cancer detection, treatment and care. Learn more about this year’s Young Investigator Awards: bit.ly/3OwhbLr #meded

Safety and dosing of lutetium-PSMA in the pre-chemotherapy #PSMAfore trial. Oliver Sartor, MD @EJHospital sits down with @zklaassen_md @GACancerCenter reviewing PSMAfore safety data showing lutetium PSMA-617 is better tolerated in chemo‑naïve mCRPC than in the heavily pretreated VISION cohort, with fewer AEs and cytopenias. Standard dosing is 7.4 GBq q6w × 6, but he stresses tailoring to bone disease burden, confirming PSMA PET positivity, and checking counts/renal function—especially as many patients now prefer #Pluvicto over chemotherapy. #WatchNow > bit.ly/3OAiOYt @PCFnews @PCF_Science

With @asco #GU26 approaching one key bit of data missing in the context of #PSMA+ #BCR #ProstateCancer management in the wake of the #EMBARK data is how does #PSA Doubling Time interface w/ #PSMA Pet findings. Dr. Melissa Abel @melissaabel20 @theNCI will share this data @ #GU26

New team picture @VHIO #prostatecancer #proudPI. Thanks to @criscancer @SaludISCIII @ContraCancerEs @FundacionFero @CDMRP @PCF_Science for supporting our group’s research!

1/11 Excited to share our study of polyamines in prostate cancer in @CR_AACR! We found that, in models of advanced PCa, supraphysiological androgens (SPA) drive production of polyamines that help the cancer survive. @PCF_Science @AACR @hopkinskimmel aacrjournals.org/cancerres/arti…

Interim #PSMAddition analysis shows lutetium PSMA-617 improves rPFS in #mHSPC. @DrScottTagawa @WeillCornell joins Oliver Sartor, MD @EJHospital to discuss on UroToday > bit.ly/4hLFCiJ @PCFnews @PCF_Science #PCFRetreat25

Study on #mHSPC survival trends. @neerajaiims @huntsmancancer discusses a Flatiron database analysis examining treatment intensification in metastatic hormone-sensitive #ProstateCancer. Dr. Agarwal emphasizes the critical need for improved implementation strategies as the field moves toward triplet therapies incorporating PARP inhibitors, lutetium PSMA-617, or AKT inhibitors, stressing the importance of making practice-changing data accessible beyond paywalls. #WatchNow on UroToday > bit.ly/3WJgfo4 @PCFnews @PCF_Science @PBarataMD

🚨 Exciting leadership opportunity at @McGillU / @MUHC: Associate/Full Professor (Clinical) to serve as Director of the Division of #Urology & Director of #Urology at the MUHC (@McGillDeptSurg). Apply here: bit.ly/4bCZNhS Please RT/share and come join us in Montréal🇨🇦!

I was glad to join @AndreaMiyahira on the digital platform of @urotoday to discuss our recent publication in 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 from the #BeltranLab on PROX1 as a driver of neuroendocrine prostate cancer progression. tinyurl.com/48z839de @mishabeltran @PCF_Science

⚠️Ask 5️⃣ radiologists to measure a #ProstateCancer lesion - get 5️⃣ different answers Important implications for AS monitoring and treatment planning Great study 👏🏼 @EurRadiology @GiorgioBre @giga_fra @PCF_Science link.springer.com/article/10.100…

Thank you @urotoday and @neerajaiims for the kind opportunity 🙏. Grateful to @PCF_Science for their support and @DrSpratticus for being there for me. @APCCC_Lugano

🙏 Thank you @ASCOPost for featuring our @Annals_Oncology paper "Machine learning reveals country-specific drivers of global cancer outcomes" led by @MilitSPatel 🔗 ascopost.com/news/january-2… @MSK_RadOnc @PCFnews

Link to the paper: sciencedirect.com/science/articl… Funded in part by @PCF_Science @PCFnews @theNCI

Thank you @soulehoward1 Dr. Soule for all your dedication, guidance, mentorship over the years! Looking forward to hearing about your next adventure!! Congratulations Dr. Miyahira @AndreaMiyahira. An outstanding choice!! I have no doubt you will carry the legacy forward and take it to an even higher level 🥳🥳 @PCFnews @PCF_Science

🗓️ Jan 30–31, 2026 | Don’t miss the @UCSanDiego @PCFnews Prostate Cancer Patient Summit — a premier gathering for patients, caregivers, advocates & clinicians. Connect with national experts, learn the latest in #ProstateCancer care, and be part of a community advancing research and support. 💙 Register Now > bit.ly/4b1puby #PCaAwareness #UCSD @PCF_Science @DrRanaMcKay

ANNOUNCEMENT: RFA for 2026 PCF TACTICAL Award Letters Of Intent for large-scale transformative team science research projects to target mechanisms of lethal #ProstateCancer LOI DEADLINE: March 16, 2026 View RFA: res.cloudinary.com/pcf/images/v17… View LOI form: res.cloudinary.com/pcf/images/v17…

Apply to join our PCF Science Team! 👇

ANNOUNCEMENT: RFA for 2026 @PCFnews Young Investigator Award Applications, for early career investigators dedicated to transformative research to end #ProstateCancer. DEADLINE: Feb 23, 2026 Apply at: pcf.smartsimple.com View the RFA: res.cloudinary.com/pcf/images/v17…